Clinical trials
Observational Lymphangioleiomyomatosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 8 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 5 |
| CENTOGENE GmbH Rostock | 1 |
| David M. Ritter | 1 |
| Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires | 1 |
| I.M. Sechenov First Moscow State Medical University | 1 |
| InCor Heart Institute | 1 |
| National Taiwan University Hospital | 1 |
| National Tuberous Sclerosis Association | 1 |
| Peking Union Medical College Hospital | 1 |
| Schön Klinik Berchtesgadener Land | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphangioleiomyomatosis | 19 |
| Tuberous Sclerosis | 8 |
| Angiomyolipoma | 3 |
| Lung Diseases | 3 |
| Asthma | 2 |
| Pneumothorax | 2 |
| Alveolitis, Extrinsic Allergic | 1 |
| Ascites | 1 |
| Astrocytoma | 1 |
| Cardiovascular Diseases | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.